Ironwood Pharmaceuticals Inc. (IRWD) and Allergan plc (AGN) announced topline data from a Phase IIb clinical trial evaluating an investigational linaclotide colonic release-2 or CR2 formulation in adult patients with irritable bowel syndrome with constipation or IBS-C.
from RTT - Biotech http://ift.tt/2h5kOTk
via IFTTT
No comments:
Post a Comment